Pharma News

24 January 2025

mRNA-activated blood clots could cushion the blow of osteoarthritis

University of Wisconsin-Madison researchers have developed a promising technique for treating osteoarthritis using therapeutic blood clots activated by messenger RNA.

Osteoarthritis is the most common form of arthritis, affecting roughly 33 million adults in the United States, according to the Centers for Disease Control and Prevention. It occurs when cartilage in key joints like the knees and hips deteriorates, causing pain and stiffness and impeding mobility.

24 January 2025

A chain reaction : HIV vaccines can lead to antibodies against antibodies

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection.

23 January 2025

Achievements under National Health Mission (2021-24) : A Milestone in Improving India’s Public Health Outcomes

The National Health Mission has significantly contributed to improving India's public health outcomes through its relentless efforts in expanding human resources, addressing critical health issues, and fostering an integrated response to health emergencies. Over the last three years, the NHM has driven substantial progress in multiple areas, including maternal and child health, disease elimination, and healthcare infrastructure. The mission’s efforts have been integral to India's health improvements, particularly during the COVID-19 pandemic, and have played a vital role in ensuring more accessible and quality healthcare services across the country.

23 January 2025

Researchers make breakthrough in bioprinting functional human heart tissue

Researchers at University of Galway have developed a way of bioprinting tissues that change shape as a result of cell-generated forces, in the same way that it happens in biological tissues during organ development.

23 January 2025

Green Tea-Based Adhesive Films Show Promise as a Novel Treatment for Oral Mucositis

Green tea shines as a natural powerhouse of antioxidants, with catechins leading the charge among its polyphenols, which protect cells from oxidative stress. These powerful compounds neutralize harmful free radicals generated during cancer treatment. The anti-inflammatory properties of green tea can alleviate oral mucositis, a painful inflammation of the mouth lining often caused by chemotherapy and radiation.

22 January 2025

Researcher Identifies PICH Protein as Key Player in Preventing Chromosome Breakage Linked to Cancer

Researchers at The University of Hong Kong have made an exciting discovery about how human cells protect DNA during cell division, offering new insights into combating diseases such as cancer. Led by Professor Gary Ying Wai CHAN from the School of Biological Sciences, Faculty of Science, and Professor Ken Hoi Tang MA from the Department of Pathology, LKS Faculty of Medicine, the research uncovers the vital role of a protein called PICH in preventing genetic errors that can lead to diseases such as cancer. Their findings were recently published in the journal Nucleic Acids Research.

21 January 2025

A major advance in biology combines DNA and RNA and could revolutionise cancer treatments

Our genes contain all the instructions our body needs to function, but their expression must be finely regulated to guarantee that each cell performs its role optimally. This is where DNA and RNA epigenetics comes in : a series of mechanisms that act as markers on genes, to control their activity without modifying the DNA or RNA sequence itself.

21 January 2025

New study paves way for immunotherapies tailored for childhood cancers

Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.

21 January 2025

Drugs for Rare Diseases - New Brunswick Agreement

The Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over 32 million USD over three years to improve access to new drugs for rare diseases for New Brunswick residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.

21 January 2025

Glenmark Pharma USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

Glenmark Pharmaceuticals Inc., USA announces the launch1 of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules. Glenmark’s Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., ANDA 087955.

Search

mRNA-activated blood clots could cushion the blow of osteoarthritis

RECOMMENDED POSTS

Subscribe with us

Jobs by Category